| (Values in U.S. Thousands) | Dec, 2018 | Dec, 2017 | Dec, 2016 | Dec, 2015 | Dec, 2014 |
| Sales | 28,970 | 33,350 | 40,600 | 33,920 | 23,930 |
| Sales Growth | -13.13% | -17.86% | +19.69% | +41.75% | +116.56% |
| Net Income | 5,520 | -19,100 | 8,790 | 12,610 | 24,690 |
| Net Income Growth | +128.90% | -317.29% | -30.29% | -48.93% | +155.85% |
Alcentra Capital Corp. (ABDC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Alcentra Capital Corporation is an externally-managed, closed-end, non-diversified management investment company that has elected to be regulated as a business development company. The Company's investment objective is to generate both current income and capital appreciation primarily by making direct investments in lower middle-market companies in the form of subordinated debt and, to a lesser extent, senior debt and minority equity investments. It seeks to invest primarily in lower middle-market companies. Alcentra Capital Corporation is based in New York.
Fiscal Year End Date: 12/31